http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1685433-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46c43cd16e1ec3dbfb550b9d1da0c428
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00772
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1988-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587d9601e7b6565d169840a76ecbcb2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd77f106b85106b6e71b7cd02854c59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_013099dadcb4c79a3d0096c0ccccc1b4
publicationDate 1991-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1685433-A1
titleOfInvention Method for treatment of purulent dacryocystitis
abstract This invention relates to ophthalmology, in particular to a method for the treatment of purulent dacryocystitis. The purpose of the invention is to reduce traumatic ™ and ensure reliable drainage. The goal is achieved by connecting the lung sac and the lower nasal passage through the lacrimal-nasal canal to a funnel tube — an endoprosthesis, for example, from corundum ceramics — to activate the upper lacrimal point through which an elastic movable mandrel is inserted into the tube, the free end of which is fixed is removed on the skin of the forehead and the mandrin is removed after removal of the external sutures. 2 Il.
priorityDate 1988-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9294

Total number of triples: 18.